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Background: Glutamate has been measured using different methods to determine its role under normal and
pathological conditions. Although microdialysis coupled with HPLC is the preferred method to study glutamate, this
technique exhibits poor temporal resolution and is time consuming. The concentration of glutamate in dialysis
samples can be measured via glutamate oxidase using the Amplex Red method.
Methods: A new device has been designed and constructed to rapidly deposit dialysis samples onto a
polycarbonate plate at Cartesian coordinates (every five seconds). The samples were added to an enzymatic
reaction that generates hydrogen peroxide from glutamate, which was quantified using fluorescence detection.
Fluorescence emission was induced by laser excitation, stimulating each spot automatically, in addition to
controlling the humidity, temperature and incubation time of the enzymatic reaction.
Results: The measurement of standard glutamate concentrations was linear and could be performed in dialysis
samples. This approach was used to determine the effect of the convulsant drugs bicuculline and 4-aminopyridine
on the extracellular glutamate concentration. Seizure activity was associated with a considerable increase in
glutamate that correlated with altered EEG patterns for both drugs.
Conclusions: These results indicate that this method is able to read samples with high temporal resolution, and it is
easy to use compared with classical methods such as high-performance liquid chromatography, with the advantage that
a large number of samples can be measured in a single experimental series. This method provides an alternative
approach to determine the concentrations of neurotransmitters or other compounds that generate hydrogen peroxide
as a reaction product.
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Due to its important role as an excitatory neurotransmitter
in the central nervous system and its role in synaptic plasti-
city, memory and learning processes, the concentration of
extracellular glutamate (Glu) has been measured under both
normal and pathological conditions [1,2]. Excess extracellular* Correspondence: amorales@cucba.udg.mx
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unless otherwise stated.Glu produces excitotoxicity and has been associated with
several neurological disorders, such as Alzheimer’s disease,
stroke, neurodegeneration and epilepsy [3-6]. To better
understand the role of Glu in normal or altered brain func-
tion, it is necessary to monitor this neurotransmitter at high
temporal resolution, particularly when behavior or electroen-
cephalography (EEG) activity are simultaneously evaluated
[7,8]. However, although behavior and EEG activity can be
studied in real time, the latency when studying the concen-
tration of Glu depends on the utilized method.
Microdialysis is the preferred method to measure
extracellular Glu concentrations, whereby samples arentral. This is an Open Access article distributed under the terms of the Creative
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quantified by high-performance liquid chromatography
(HPLC). This method is reliable, and although it is con-
sidered to be the method of reference, it is frequently as-
sumed to exhibit poor temporal resolution because a
minimum volume is required to perform this analysis
and a flow rate of 2.0 μl/min is generally used. Because
the temporal resolution when using microdialysis typic-
ally depends on the speed of sample collection, although
rapid collection improves the temporal resolution, it
may also generate a bottleneck, given the challenge of
measuring the large number of samples that can be ob-
tained using this classic technique. Nevertheless, by
coupling the microdialysis technique to capillary electro-
phoresis (CE) with laser-induced fluorescence detection
(LIFD), it has been possible to measure extracellular Glu
concentrations in dialysate samples at one and ten sec-
ond resolution, respectively [9,10]. This procedure offers
the advantage of improving the temporal resolution with
respect to the classic HPLC methods, although handling
such small sample volumes may be an important issue
to consider due to evaporation. Another important ad-
vantage of HPLC and CE is that a group of compounds
sharing similar physicochemical properties, such as
monoamines or amino acids, can be separated, identified
and quantified in the same sample.
Monitoring a particular neurotransmitter such as Glu
at high temporal resolution using HPLC or CE can be
time consuming, and considerable training is required,
in addition to the cost of these devices. The recent intro-
duction of biosensors is gradually generating additional
possibilities to study rapid neurochemical changes, such
as those in Glu, acetylcholine [11] and metabolic agents
such as glucose and lactate [12]. These biosensors are
based on the use of oxidases that generate hydrogen per-
oxide (H2O2), with oxidation occurring on a platinum
electrode at positive potential. Biosensors can be used to
monitor Glu concentrations at enhanced time reso-
lution, allowing behavior and EEG activity to be simul-
taneously investigated [8,13]. Currently, biosensors are
available in smaller sizes that incorporate more advanced
technologies (Quanteon, LLC).
The use of biosensors opens the possibility of
obtaining sufficient temporal resolution to correlate
the changes in neurotransmitters with biochemical
data. However, biosensors are primarily used to moni-
tor a single neurotransmitter at a time, and in the case
of acetylcholine, they do not distinguish choline from
acetylcholine, although multiplexed electrodes covered
with different enzymes have been used to evaluate
more than one neurotransmitter, such as monoamines.
Moreover, biosensors for other important neurotransmit-
ters, particularly for GABA, remain to be developed, al-
though the utilization of GABAse and glutamate oxidaseto generate current for the electrochemical detection of a
H2O2 derivate using these sets of reactions has been re-
ported [14]. Additionally, using electrochemical biosensors
for the simultaneous monitoring of neurotransmitters with
measurement of low field potential results in similar sig-
nals, particularly those at low frequency; therefore, distin-
guishing the chemical signal from the electrical signal may
be an important issue, which may be resolved through the
use of a pure chemical method. Another important issue
with the use of an electrochemical biosensor method is
that a large potential is generally applied to generate the
expected current. A decrease in sensitivity is observed that
has been associated with fouling of the electrode surface
due to the deposition of undesired compounds, hindering
the establishment of a steady baseline for the neurotrans-
mitter concentration. In this respect, the application of a
particular coating over the electrodes has been used to in-
hibit or retard adhesion to the surface [15]. An alternative
approach to determine neurotransmitter concentrations in
biological fluids at high temporal resolution involves the
use of enzymatic reactors. This approach provides new op-
portunities to develop and design enzymatic reactions to
obtain “a derivate” that can be measured by fluorescence,
luminescence and electrochemical detection systems, or
even by other systems of detection. Indeed, several kits are
currently available that measure Glu and acetylcholine
using fluorescence (Amplex Red, Invitrogen), although
these approaches require relatively large volumes of these
compounds. Although the use of enzymatic reactors does
not exhibit differences in specificity compared with biosen-
sors, these approaches may offer the major advantage of
preserving a more naive enzyme and its molecular proper-
ties; moreover, the enzymes are not denaturalized or re-
stricted in a polymeric matrix such as in biosensors, which
may decrease their affinity for their substrates [16]. In
addition, other factors such as temperature, time incuba-
tion, and ionic strength, among other conditions, can be
better controlled using these approaches.
Therefore, the objective of this study was to develop a
device that utilizes the Amplex Red method to measure
Glu in small dialysis samples. Dialysate samples from dialy-
sis tubes were mixed with a similar volume of an enzym-
atic reactor and automatically deposited under humid
conditions on a polycarbonate plate at specific Cartesian
coordinates. The samples were allowed to react, and the
fluorescence was subsequently measured using a charge-
coupled device (CCD) detector following laser excitation of
each sample. We evaluated this method in seizure models
induced by the GABAA receptor antagonist bicuculline
and by administration of the potassium channel blocker 4-
aminopyridine (4-AP), as well as through electrical stimu-
lation. The obtained results clearly demonstrate that the
enzymatic reactor can be adapted to monitor neurotrans-
mitters in dialysate samples at high temporal resolution
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represent a suitable approach to avoid the separation re-
quired for chromatographic methods, and it provides a
means to measure many samples in a single session, saving
valuable time and reagents.
Results
Setup and calibration
The designed device constructed for these studies fulfilled
the sampling and fluorescence reading requirements ac-
cording to the desired protocol. The device could be satis-
factorily programmed without errors, neither during
deposition nor during the reading of the samples. Add-
itionally, the humidified chamber that was coupled to the
sampling stage was crucial in preventing sample evapor-
ation, allowing the reaction to proceed despite incubation
at room temperature. The incubation time (60 min) for
each sample prior to reading was maintained constant, and
the fiber optic arrangement enabled the light to be emitted
directly over the samples and to detect the light emitted
following excitation. The fiber optics was mounted through
a micromanipulator to assess their exact position in each
experiment. Different intensities of laser power were evalu-
ated to obtain the best response, and 5 mW was found to
be the optimal power to excite the samples and obtain the
strongest fluorescence response. For the CCD-based fluor-
escence detector, it was possible to use the software to
synchronize the time of reading (every five seconds) with
the movement of the platform such that the reading could
be performed automatically. Accordingly, the time required
for reading depended on the total number of deposited
samples. This process offers the advantage of measur-
ing an experimental series in a single session, and
using the SpectraSuite software (Ocean Optics), the
analysis could be performed simultaneously during
the reading. Thus, a total of 900 samples could be
evaluated in approximately 75 min. A scheme of the
device is presented in Figure 1.
To evaluate the viability of the enzymes used to pre-
pare the reactor, standard concentrations were run
prior to experiments to determine calibration curves, and
similar results were obtained for each calibration curve (a
representative calibration curve is shown in Figure 2).
These assays ensured that the reactor was in conditions to
perform the experiments in animals, and a linear increase
was observed in the fluorescence obtained with each in-
crease in the standard Glu concentration. A total of 720
samples were deposited on the plate, testing 120 blank
samples and 600 samples of the five evaluated standard
concentrations; the value of the blank samples was sub-
tracted from the data obtained from the experiments to
calculate the actual Glu concentration. An average of the
data obtained for each concentration (120 samples) from
each experiment was calculated for linear regressionanalysis (r2 = 0.98). Some fluctuations appeared during the
reading process that was more evident at higher concentra-
tions of the different evaluated standards. Although the ori-
gin of these fluctuations is unclear, these fluctuations may
result from mixing of the sample inside of the tubing,
which may be reduced by including a mixing chamber, not
excluding errors during the detection of fluorescence emis-
sion. Additional studies are necessary to confirm this
speculation.
EGG recordings and in vivo microdialysis studies
To evaluate the different protocols, 5 rats were used, each of
which exhibited normal electrical activity prior to testing.
This activity was characterized by slow physiological waves
of low amplitude and frequency (LPCSF, Figure 3), and an
increase, particularly in amplitude, was observed in most
evaluated regions following HPCSF administration to the
RPH (RAH 570.3 ± 233, LAH 705.6 ± 234, RPH 1069.3 ±
422 and LPH 1497.2 ± 726 μV). In contrast, only a small in-
crease in frequency was detected (RAH 4.3 ± 0.7, LAH 4.0
± 0.8, RPH 3.4 ± 0.6 and LPH 3.6 ± 0.6 Hz), and both of
these parameters returned to the basal state during subse-
quent LPCSF administration. In contrast to the changes pro-
duced by HPCSF administration, both the amplitude and
the frequency remained close to the basal level of electrical
activity during electrical stimulation in the four analyzed re-
gions (RAH 547.6 ± 146, LAH 510.7 ± 116, RPH 514.2 ± 188
and LPH 561.4 ± 90 μV; RAH 4.6 ± 0.4, LAH 3.6 ± 0.6, RPH
2.9 ± 0.7 and LPH 3.0 ± 0.7 Hz), and similar basal electrical
activity persisted following LPCSF administration.
Bicuculline administration produced intense epilepti-
form activity in all evaluated regions (Figure 3), with an
average latency for the appearance of epileptiform dis-
charges of 2.6 ± 0.1 min. The maximum amplitude of the
first epileptiform discharge was observed in the RPH
(2867.6 ± 567 μV, p < 0.001) and the minimum amplitude
in the LAH (2275.2 ± 477 μV, p < 0.001), whereas the
maximum frequency was observed in the LPH (9.0 ±
2.7 Hz, p < 0.001) and the minimum frequency in the
RAH (5.2 ± 2.0 Hz, p < 0.001). Although a small decrease
in the amplitude of epileptiform discharges in all of the
evaluated regions (RAH 1445 ± 339, LAH 1604.6 ± 436,
RPH 1804.2 ± 304 and 1542 ± 393 μV) was observed at
the end of the experiment, a general increase in the fre-
quency of this epileptiform activity was also observed
(RAH 16.9 ± 6.9, LAH 17.4 ± 7.0, RPH 8.1 ± 3.1, and
LPH 10.2 ± 3.0 Hz).
The neurochemical data revealed a basal glutamate
level of 4.7 ± 0.06 μM. During HPCSF administration,
a small discrete increase in Glu of 27.1% (6.0 ±
0.44 μM) was observed that was correlated to the
small increment in the amplitude and frequency of
electrical activity (Figure 3). The stimulation protocol
also produced an increase in Glu of 14.2% (5.4 ± 0.18 μM)
Figure 1 The device developed for sampling and reading of the glutamate concentration in dialysates. Top of A and B show the
schematic device with all of its components: 1, the cover; 2, the stage movable in two axes; 3, the Z axis with the needle for sampling; 4,
polycarbonate plate; 5, the control box used to program the device in terms of the number of rows and the frequency of the sampling process,
as well as for reading; and 6, space for a wet sponge to create the humidity chamber when the cover slides over it. Actual images of the
schematic device are shown at the bottom. C, Schematic and actual images (top and bottom, respectively) of fluorescence samples obtained at
the end of an experiment.
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contrast, a strong 97.6% increase in Glu was observed
during the first epileptiform discharge induced by
bicuculline administration (9.3 ± 0.38 μM, Figure 3).
In addition, an additional increase in Glu was evident andFigure 2 Representative calibration curve with different concentratio
units (AFU) in 720 samples collected every 5 s. The first 120 samples were
with the five evaluated standard concentrations (5, 10, 20, 50 and 100 μM).
obtained from each experiment and the linear regression analysis of all calpersisted throughout the period of seizures before the death
of the animals (149% with respect to the baseline level, 11.7
± 1.3 μM; p = 0.0017). This increase was coincident with
the period of constant high amplitude and frequency epi-
leptiform activity induced by bicuculline (Figure 3).ns of glutamate (Glu). Glu was measured in arbitrary fluorescence
analyzed without Glu, and the remaining 600 samples were analyzed
The plot in the inset shows the mean (±SEM) of each concentration
ibration curves prior to the experiment (r2 = 0.98).
Figure 3 Representative experiment in which glutamate (Glu) was simultaneously measured with EEG in the first experimental group.
The temporal course represents the Glu measured in arbitrary fluorescence units (AFU) every five seconds and the intracranial EEG recording
obtained from different evaluated regions (right and left anterior hippocampus: RAH and LAH, respectively; right and left posterior hippocampus:
RPH and LPH, respectively; d, deep microelectrode positioned at a 1.5 mm vertical tip separation from its pair) in 15-s segments during the
administration of 1) low-potassium artificial cerebrospinal fluid (LPCSF), 2) high-potassium artificial cerebrospinal fluid (HPCSF), 3) LPCSF, 4) LPCSF
+ electrical stimulation (ES; duration: 0.1 ms; current: 0.5 mA every 10 s), 5) LPCSF, and 6) LPCSF + bicuculline (BIC, 8 mg/kg, i.p.). The plot in the
inset corresponds to the mean (±SEM) of the Glu concentration in μM during the different evaluated protocols (n = 5). The value in each bar was
obtained by averaging 10 min of sampling (120 samples). •Onset of epileptiform activity; †time of death of the animal while seizing; *p < 0.05 vs.
other protocols.
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tude and frequency of activity was low during basal ac-
tivity (RFC 154 ± 29, LFC 192 ± 43, ROC 217 ± 35, LOC
248 ± 33 and RPH 467 ± 41 μV; RFC 1.7 ± 0.4, LFC 2.2 ±
0.1, ROC 2.5 ± 0.3, LOC 2.3 ± 0.2 and RPH 1.7 ± 0.2 Hz).
Indeed, during HPCSF administration, only one 30-s
period with interictal spikes was observed (RFC 381,
LFC 579, ROC 614, LOC 795 and RPH 4120 μV), and
the frequency did not differ from the basal electrical ac-
tivity (1.5-3.5 Hz). The administration of 4-AP produced
an initial epileptiform discharge after 120 s, with a
marked increase in amplitude that was primarily evident
in the RPH (RFC 98 ± 10, LFC 152 ± 9, ROC 371 ± 10,
LOC 221 ± 14 and RPH 2702 ± 104 μV; RFC 3.0 ± 0.2;
LFC 2.0 ± 0.3, ROC 2.0 ± 0.3, LOC 3.0 ± 0.7 and RPH2.0 ± 0.7 Hz). Subsequent epileptiform activity was char-
acterized by polyspike trains and synchronized spike
wave activity associated with high amplitudes and fre-
quencies (RFC 209 ± 30, LFC 189 ± 20.8, ROC 370 ± 52,
LOC 326 ± 33.2 and RPH 1925 ± 155.6 μV; RFC 3.0 ±
0.6; LFC 5.0 ± 1.3, ROC 5.0 ± 1.8, LOC 4.0 ± 1.1 and
RPH 5.0 ± 1.5 Hz). These changes were more evident in
the RPH area, close to the point of 4-AP administration
(Figure 4).
These rats had a basal Glu concentration of 4.4 ±
0.07 μM, which increased significantly during HPCSF
perfusion to 18.4 ± 0.05 μM. This alteration was associ-
ated with the interictal spikes observed in the EEG re-
cordings. Moreover, 4-AP administration was correlated
to an increase of 47.7 ± 0.76 μM in the RPH associated
Figure 4 Representative experiment in which glutamate (Glu) was simultaneously measured with EEG in the second experimental
group. The plot represents the temporal course for glutamate (Glu) levels in arbitrary fluorescence units (AFU) observed every five seconds
throughout a representative experiment (n = 4), and the EEG recording in segments of 30 s during administration of low-potassium artificial
cerebrospinal fluid (1), high-potassium artificial cerebrospinal fluid (HPCSF, 2 and 3 with interictal spikes), and 4-aminopyridine (4-AP; administered
over 10 min through the microdialysis probe, 4–12; 25 mM).
Medina-Ceja et al. BMC Neuroscience  (2015) 16:11 Page 6 of 11with the strong convulsive behavior and epileptiform ac-
tivity that appeared in all of the evaluated regions. Inter-
mittent Glu alterations were observed throughout the
experimental procedure and were correlated to alter-
ations in the EEG and convulsive behavior (Figure 4). All
of the neurochemical data were correlated to the EEG
following correction for the dead time latency (7 min).
Discussion
We have developed a device for the rapid sampling and
measurement of small volumes of microdialysis samples
(Innova Cielec, SA de CV, Tonalá, Jalisco, México). This
device can be programmed in several ways, such as based
on the time and number of samples to be deposited on the
platform, such that large numbers of samples can be rap-
idly analyzed (in this case, greater than 700 samples in a
single 60-min session). The sampling and reading proced-
ure is highly reproducible and does not produce mechan-
ical or electronic errors. The humidity chamber used with
this device was sufficient to prevent sample evaporation,
allowing the samples to remain in solution throughout the
experiment and for several additional hours. To evaluate
its functionality, calibration curves were determined, and
the average linear regression analysis was 0.96 in most ofthe sessions. However, apparent noise was observed with
increasing Glu concentration, which may be due to the fil-
ter used (grid window); improved filtering of light emission
may reduce this noise. With these functional characteris-
tics, the device could be used to analyze several neuro-
transmitters (Glu in this case) that can be measured with
enzymatic reactors that generate H2O2 as a reaction
product.
In the present study, this device was used to measure
changes in the Glu concentration correlated to EEG record-
ings of rats treated with bicuculline or 4-AP in small dialysis
samples at high temporal resolution. The fluctuations ob-
served during calibration increased with higher Glu con-
centrations. As previously mentioned, these fluctuations
may result from mixing of the sample inside of the tubing;
including a mixing chamber may aid in reducing these fluc-
tuations, although we cannot exclude the possibility of er-
rors during the fluorescence readings. The use of an optical
shutter to block undesired light between each measurement
may aid in preventing these fluctuations, which limit the
ability to detect concentrations less than 1.0 μM. Further
optimization of the performance of this instrument would
improve the limit of detection. The baseline Glu concentra-
tion (in μM) is similar to the concentration obtained using
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detection (2.8 μM/1.5 μM). This small difference between
these two methods may be due to the cut-off of the
dialysis membrane. For the HPLC-based methods, a
6 kDa cut-off membrane was used, and, particularly
for the lowest concentration determined by fluoro-
metric detection, the experiments were performed
under anesthesia; in the present set of experiments, a
20 kDa cut-off membrane was used, which results in
better recovery, and the animals were not under
anesthesia [7,17]. Although the method used in this
study does not have the limit of detection of electro-
chemical or fluorescence HPLC methods, it demon-
strates sufficient sensitivity to monitor a clear baseline
Glu concentration during normal physiological activ-
ity; considering a 3:1 signal-to-noise ratio, the limit of
detection for determination of the Glu concentration
in each sample was 1.0 μM. Additionally, the signal
fluctuation present throughout the experimental pro-
cedure may be due to the form of the samples on the
polycarbonate plate, i.e., they are not flat or embedded
in a polymeric matrix, which permits enhanced fluor-
escence detection. Additional studies on instrument
optimization are currently ongoing to prevent these
fluctuations. The results indicated that discrete in-
creases in the Glu concentration (27.1%) were corre-
lated with a small increment in the amplitude and
frequency of electrical activity, particularly using the
HPCSF protocol in rats that received bicuculline. More-
over, when interictal activity was present during HPCSF
administration in the animals that received 4-AP, a signifi-
cant increase in the Glu concentration (300%) was ob-
served. These results are consistent with our previous
studies [6,7], in which a threefold increase in the Glu con-
centration was provoked by HPCSF administration. In
addition, weak electrical stimulation (duration: 0.1 ms;
current: 0.5 mA every 10 s/10 min) to the right angular
bundle that did not produce pronounced changes in elec-
trical activity was sufficient to increase the Glu concentra-
tion (14.2%). This result may indicate that the release of
Glu evoked by electrical stimulation is not sufficiently
strong to synchronize the electrical activity of a neuronal
population and produce significant changes in EEG re-
cordings. This finding is in contrast to the correlation be-
tween low-frequency stimulation-evoked Glu currents and
the slopes of the field excitatory postsynaptic potentials
[18] (fEPSPs). Conversely, bicuculline administration pro-
duced a significant increase in the Glu concentration
(97.6%) that was correlated with the first epileptiform dis-
charge and persisted throughout the experimental proced-
ure (149%), together with the epileptiform activity. Indeed,
bicuculline administration through different routes pre-
ceded the increase in extracellular Glu. For example, the
Glu concentration increased approximately 100% in therat hypothalamus following intracerebroventricular ad-
ministration of 0.3 nmol bicuculline in the absence of gen-
etic epileptic predisposition [19], whereas the infusion of
bicuculline (100 μM) through a microdialysis probe in-
creased Glu levels by 46% in the ventral hippocampus
[20]. In both of these studies, a traditional HPLC system
coupled to electrochemical detection was used to measure
microdialysis samples collected every 20 min, with offline
analysis. Neither of these studies adequately correlated the
EEG activity with the neurochemical data. In the kainate
model of epilepsy, a 2- to 6-fold increase in Glu was ob-
served in association with the frequency and magnitude of
electrographic seizures in the hippocampus [21]. Never-
theless, this study used 2 min microdialysis samples,
fluorometric detection and offline analysis, a methodology
that does not permit a detailed correlation with the precise
onset of the electrographic seizures. Other studies demon-
strated bicuculline to be a competitive antagonist of the
GABA binding site in the GABAA receptor, as well as pro-
ducing prolonged Ca2+ action potentials and blockade of
K+ channels [22], effects that produce seizures. During sei-
zures, bicuculline was also found to induce high-
amplitude and frequency polyspike discharges, followed
by clonic paroxysmal activity of lower frequency [23].
These results are consistent with the epileptiform activity
observed in the present study. The microdialysis proced-
ure is generally related to the extracellular neurotransmit-
ter concentration, which may originate from synaptic
activity and reverse Glu transport mediated by trans-
porters localized both in neurons and in glia [24]. Add-
itional experiments should be conducted to determine the
source of Glu, such as using tetrodotoxin to block synaptic
release. However, during HPCSF and bicuculline adminis-
tration, significant increases in Glu were found that may
be related to synaptic activity, as previously discussed
[20,25]. Although probe insertion produces significant tis-
sue damage that results in an immediate increase in the
Glu concentration, in this study, an increase due to probe
damage can be excluded because the probe was allowed to
stabilize to reach a baseline level prior to the experiments.
Therefore, the measured Glu primarily originates from the
intact tissue surrounding the microdialysis probe.
We also evaluated the convulsive effect of 4-AP to dem-
onstrate the correlation between Glu release and epilepti-
form activity measured with this novel device. As observed
for animals treated with bicuculline, animals treated with
4-AP exhibited a close correlation between increased Glu
and electrical activity. During HPCSF administration, an
increase in Glu levels was correlated with interictal spike
periods, whereas during 4-AP administration, the Glu con-
centration peaked in association with the first epileptiform
discharge. In this experimental group, the observed Glu in-
crease may originate from synaptic terminals because 4-AP
is known to block potassium channels, increasing the
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transmitter release [26]. Previous studies attempted to cor-
relate electrical activity with Glu levels following 4-AP
administration [7,27,28], with high Glu concentrations
found during electrographic seizures. However, the time-
scale over which the dialysis samples were collected was
long, and in the best case, the samples were collected every
60 s, rendering it difficult to correlate them to physiological
events.
Although microdialysis is the traditional technique used
to measure Glu concentrations during brain activity, its
low temporal resolution, with minimal temporal intervals
of one or two minutes, renders it difficult to correlate rapid
brain electrical activity with the neurotransmitter concen-
tration. Although several studies have attempted to meas-
ure Glu levels at higher time resolution in small volumes
[9,10,29], these studies typically required expensive equip-
ment and involve time-consuming procedures, relying on
specialized techniques that require specific training to per-
form. Although biosensors are currently widely used and
their use is emerging as a popular method to determine
neurotransmitter concentrations, additional effort is on-
going to obtain more reliable data. Optimization of the
techniques presented in this study (i.e., electrochemical
and optical biosensors combined with the rapid sampling
of microdialysis samples) may offer a better means of es-
tablishing a correlation between electrophysiological and
biochemical activity.
Conclusions
The device we have developed and present herein provides
a good alternative to measure Glu concentrations with suf-
ficient temporal resolution for correlation of rapid elec-
trical activity with neurochemical changes in samples
collected every five seconds. This device is less expensive
to use and easy to handle compared with other devices that
may be capable of achieving a similar resolution. Using this
device, we correlated increases in the Glu concentration
with the interictal spike period during HPCSF administra-
tion or with the first epileptiform discharge provoked by
bicuculline or 4-AP. Although these results are consistent
with other studies demonstrating high Glu levels during
epileptiform activity, it has not been previously possible to
correlate these events this closely, and previous results
were based on the accumulation of Glu during longer mi-
crodialysis collection times.
Methods
Enzymatic glutamate assay and the developed device
The assay used in this study has been shown to provide a
sensitive means to detect extracellular Glu and is a tested
method utilized in commercially available kits to determine
the concentrations of several compounds using Amplex
Red (Invitrogen, San Diego, CA, USA). Briefly, Glu isoxidized by glutamate oxidase to produce α-ketoglutarate,
NH3 and H2O2. The reaction includes L-alanine and L-
glutamate–pyruvate transaminase to regenerate L-Glu by
transamination of α-ketoglutarate, amplifying the H2O2
produced by permitting multiple cycles of the initial reac-
tion. The generated H2O2 is measured with Amplex Red
(10-acetyl-3,7-dihydroxiphenoxazine), which is a fluoro-
genic probe that reacts with H2O2 in the presence of
horseradish peroxidase in a 1:1 stoichiometric ratio, produ-
cing resorufin [30,31]. Resorufin fluoresces at 590 nm
when excited at 560 nm, and this fluorescence can be read-
ily measured in small cuvettes [28].
Standard solutions were prepared by diluting Glu in arti-
ficial cerebrospinal fluid (aCSF) containing the following
salts (in mM): NaCl (125); KCl (2.5); NaH2PO4•H2O
(0.90); Na2HPO4 (5); MgCl2•6H2O (1.0); and CaCl2 (2.2).
An enzymatic reactor was prepared by mixing glutamate
oxidase (0.1 U/ml), horseradish peroxidase (0.25 U/ml), L-
alanine (200 μM), and L-glutamate–pyruvate transaminase
(0.1 U/ml). All enzymes and reagents were obtained from
Sigma-Aldrich (St. Louis, MO, USA), and Amplex Red
(100 μM) was obtained from Invitrogen (San Diego, CA,
USA). Calibration curves were obtained by mixing the
standard solutions with the enzymatic reactor through a
“Y” connector needle attached to a linear actuator
(“Z” axis). This needle was equipped with a spring
buffer that permitted the samples to be placed onto
the plate without the needle bending and reaching the
surface. One inlet was used to feed the reactor solution,
and a second inlet was used for the standard solution or di-
alysate from the animals. Two microdialysis syringe pumps
(Bioanalytical Systems, Inc., West Lafayette, USA) were
used to simultaneously administer the reactor and the
standard solution or dialysis samples, and the mixture exit-
ing from the “Y” connector was periodically deposited at
Cartesian coordinates onto a polycarbonate plate placed
over a motorized X, Y stage. Customized hardware and
software were developed to program the number of rows
and columns to be deposited on the plate, as well the fre-
quency of sampling, in these experiments every five sec-
onds (Innova Cielec SA de CV, Tonalá, Jalisco, México).
Individual syringes were filled with several standard solu-
tions, and two rows of 30 samples were deposited on the
plate. The following consecutive concentrations of Glu
were evaluated using a liquid switch: 5, 10, 20, 50 and
100 μM. Because the flow rate of both syringes was 2.5 μl/
min, the volume deposited in each sample was approxi-
mately 400 nl every five seconds. To prevent evaporation
of these small volumes, a humidified chamber was con-
structed over the plate, permitting mobility in the Z axis to
deposit the respective samples. With this setup, it was pos-
sible to maintain the humidity of the samples for long periods
of time, even up to 48 h (Figure 1A and B). This proced-
ure was performed prior to each in vivo experiment.
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ple, a fluorescence reading system was coupled to this
device that consisted of a CCD detector (Ocean Optics).
To excite the samples, a laser light source was used
(561 nm wavelength; Opto Engine LLC, China), con-
ducting the light to the sample through fiber optics
(400 μm in diameter) placed approximately 1 mm above
the sample. The distance and laser intensity were set at
5 mW to excite and obtain an adequate fluorescence sig-
nal. To detect the fluorescence intensity, another optical
fiber (600 μm) was placed at a similar distance but at 90°
with respect to the excitation source. Once the emission
was detected and filtered (590 nm wavelength), the
fluorescence was sent to the detector (Figure 1C). The
measured fluorescence intensity was used to obtain the
calibration curves and evaluate the reliability of this pro-
cedure. Additionally, the fluorescence intensity obtained
for the samples was extrapolated to the values obtained
in the calibration curves. Fluorescence values of the
standards and samples that were larger than three times
the standard deviations obtained at zero Glu concentra-
tion (blank) were considered actual concentrations and
were used to determine the limit of detection (1.0 μM).
Animals and surgery
All experimental procedures were designed to minimize
animal suffering and the total number of animals used.
All rats were maintained in individual cages in a
temperature-controlled room on a 12 h light/dark cycle
with access to food and water ad libitum. This protocol
conformed to the Rules for Research in Health Matters
(Mexican Official Norms NOM-062-ZOO-1999, NOM-
033-ZOO-1995) and was approved by the local Animal
Care Committee.
Extracellular Glu was measured in nine animals; the first
group consisted of five adult male Wistar rats (250–350 g)
following different experimental protocols, such as the ef-
fect of a high-potassium solution, electrical stimulus and
bicuculline (i.p. administration), and a second group of
four animals was used to measure Glu following 4-AP ad-
ministration (reverse microdialysis procedure). The ani-
mals were anesthetized with isoflurane in 100% O2 and
secured in a Stoelting stereotaxic frame with the incisor
bar positioned at −3.3 mm. A pair of tungsten microelec-
trodes (60 μm in diameter) was implanted in the right an-
gular bundle to stimulate the perforate pathway (AP
−7.00 mm from bregma; ML −4.00 mm; DV −2.5 mm
from the superficial neocortex), with a vertical separation
of 0.5 mm between the tips. Two fixed microelectrodes (bi-
polar microelectrodes) were assembled with the same char-
acteristics as the stimulation microelectrodes but with a
1.5 mm vertical tip separation, and they were implanted in
each evaluated region, as follows: left and right posterior
hippocampus (LPH, RPH: AP −5.0 mm from bregma; ML± 5.0 mm; DV −5.5 mm), left and right anterior hippocam-
pus (LAH, RAH: AP −3.5 mm; ML ± 2.00 mm; DV
−4.0 mm). A stainless steel guide cannula (0.5 mm internal
diameter) was implanted into the right posterior hippo-
campus (AP −5.0 mm; ML −5.0 mm; DV −5.5 mm), and
this cannula was used to insert the dialysis probe. All mi-
croelectrodes were attached to a socket connector and, to-
gether with the guide cannula, were fixed to the skull with
acrylic dental cement. To evaluate the effect of the convul-
sant drug 4-AP, a different surgical procedure was per-
formed on four animals, attaching four superficial
electrodes to the right and left frontal (RFC, LFC) and oc-
cipital (ROC, LOC) cerebral cortex and introducing a bipo-
lar deep microelectrode into the guide cannula in the RPH.
Drug administration and microdialysis
Three days after surgery, a CMA-12 microdialysis probe
(0.5 mm in diameter, 3 mm in length and 20 kDa cut-
off ) was inserted into the hippocampus. The probe was
flushed with HPLC-quality water at a flow rate of 10 μl/
min for 5 min prior to insertion, after which the fluid so-
lution was switched to a filtered, low-potassium, artificial
cerebrospinal fluid (LPCSF) adjusted to pH 7.4 with
CO2 that contained the following (in mM): NaCl (125),
KCl (2.5), NaH2PO4 (0.9), Na2HPO4 (5), MgCl2 (1), and
CaCl2 (2.2). Following insertion, the probe was allowed
to equilibrate for at least 2 h at a flow rate of 2.5 μl/min,
followed by simultaneous EEG recording and fraction
collection. Samples were collected every five seconds
and mixed with an equivalent volume of the enzymatic
reactor throughout the experimental procedure, and the
basal Glu concentration was determined in each experi-
ment from the first 120 samples. The perfusion solution
was then changed to a high-potassium solution (HPCSF,
100 mM KCl in aCSF with a reduced NaCl concentra-
tion to adjust the osmolarity), which was flushed
through the probe for ten minutes at the same flow rate.
The LPCSF was then flushed through the probe for an
additional 10 min prior to application of the electrical
stimulation for 10 min (duration: 0.1 ms; current:
0.5 mA every 10 s), and the probe was once again
flushed with LPCSF for 10 min prior to administration
of bicuculline (8 mg/kg, i.p.; antagonist of the GABAA
receptor (Sigma-Aldrich, St. Louis, MO, USA)).
In another series of experiments, a similar protocol was
followed without testing the electrical stimulation, in which
after a 2-h recovery period, HPCSF and 4-AP (25 mM)
were administered through the microdialysis probe for
10 min each, with administration of LPCSF in between. To
correlate the biochemical changes with the EEG electrical
activity, it was necessary to determine the dead latency
time, which was calculated in vitro by immersing the same
microdialysis probe inside a beaker that contained a known
Glu concentration and collecting consecutive samples, as
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cence could be measured.
EEG recording
Intracranial EEG recordings were obtained using a Grass
7D polygraph with eight amplifiers. Electrical stimulation
was performed using a Grass (S44) stimulator with the fol-
lowing parameters: high band filter of 0.1 Hz and low band
filter of 3 kHz with a sensitivity 75 μV/cm, acquisition in
each channel of 3 kHz, and a precision of 12 bit. The data
were stored on external hard disks for subsequent analysis.
The electrical signals were analyzed on a Macintosh A1048
computer using AcqKnowledge 3.9.1 software from BIO-
PAC Systems (California, USA). The parameters of the an-
alyzed electrical signals were the amplitude and frequency
(mean ± SEM) in periods of 15 s during the different chem-
ical and electrical protocols in the first set of experiments,
and periods of 5 s were analyzed to evaluate the effect of 4-
AP administration.
Histological evaluation
At the end of each experiment, the placement of the guide
cannula was verified. The animals were anesthetized with
sodium pentobarbital and transcardially perfused with
100 ml of normal saline (0.9%) in 0.12 M buffer/CaCl2,
followed by 300 ml of 4% paraformaldehyde in 0.12 M buf-
fer/CaCl2 (pH 7.3). Coronal sections (50 μm thick) of the
animal’s brain were stained with cresyl violet, and animals
in which the cannula reached the exact required position
were included in the study.
Data analysis
The results are expressed as the means (±SEM), and
comparisons were made between different protocols
using the GraphPad Prism 5 statistical software package
by applying a one-way analysis of variance (ANOVA)
with Dunnett’s and Tukey’s post hoc tests. Statistical sig-
nificance was considered at p < 0.05.
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